IMAC Holdings, Inc. (BACK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
IMAC Holdings, Inc. (BACK) trades at $0.04 with AI Score 39/100 (Grade D). IMAC Holdings, Inc. operates outpatient medical clinics providing regenerative and minimally invasive therapies. Market cap: $151,399, Sector: Healthcare.
Price live · AI analysis from May 31, 2026Analyst Coverage for BACK: BACK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BACK against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BACK: 1/1 perspectives are bearish.
How is this calculated? →IMAC Holdings, Inc. (BACK) Healthcare & Pipeline Overview
IMAC Holdings, Inc. operates in the healthcare sector, managing outpatient medical clinics that offer regenerative, orthopedic, and minimally invasive procedures. With a focus on treating sports injuries and musculoskeletal conditions, the company manages 15 clinics across several states, positioning itself in the growing market for non-surgical pain management solutions.
What Is the Investment Thesis for BACK?
IMAC Holdings, Inc. operates in the healthcare sector, specifically within medical care facilities, offering regenerative and minimally invasive procedures. The company's growth potential lies in the increasing demand for non-surgical pain management and regenerative therapies. However, with a negative profit margin of -42693.2% and a negative gross margin of -1838.8%, the company faces significant financial challenges. The company's high beta of 1.70 indicates higher volatility compared to the market. The ability to scale its clinic operations and improve financial performance will be critical for long-term sustainability. The company's success depends on effective marketing, patient acquisition, and efficient management of its 15 clinics.
Based on FMP financials and quantitative analysis
BACK Key Highlights
- Operates 15 outpatient medical clinics across six states: Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida.
- Focuses on regenerative, orthopedic, and minimally invasive procedures and therapies.
- Provides treatments for sports injuries, ligament and tendon damage, and other soft tissue conditions.
- Offers physical therapy, spinal decompression, and chiropractic manipulation.
- Trades on the OTC market, indicating higher risk and lower liquidity.
Who Are BACK's Competitors?
BACK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BACK's Key Strengths?
- Specialized in regenerative and minimally invasive procedures.
- Network of 15 outpatient medical clinics.
- Focus on non-surgical pain management.
- Experienced management team.
What Are BACK's Weaknesses?
- Negative profit margin of -42693.2%.
- Negative gross margin of -1838.8%.
- High beta of 1.70 indicates higher volatility.
- Trades on the OTC market, indicating higher risk.
What Could Drive BACK Stock Higher?
- Potential partnerships with major healthcare providers in Q3 2026.
- Increasing demand for non-surgical pain management solutions.
- Expansion of regenerative medicine market.
What Are the Key Risks for BACK?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin of -42693.2%.
- Negative gross margin of -1838.8%.
- Regulatory changes in the healthcare industry.
- Competition from other medical care facilities.
- High beta of 1.70 indicates higher volatility.
What Are the Growth Opportunities for BACK?
- Expansion into New Markets: IMAC Holdings, Inc. can expand its footprint by opening new clinics in underserved markets. The market for outpatient medical services is growing, with a projected annual growth rate of 5-7% over the next five years. By strategically targeting regions with a high demand for regenerative and minimally invasive procedures, IMAC can increase its revenue and market share. This expansion should be focused on areas with favorable demographics and healthcare infrastructure, with a timeline of 2-3 new clinics per year.
- Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, orthopedic practices, and sports medicine clinics can drive patient referrals and increase brand awareness. Forming strategic alliances with established healthcare providers can provide IMAC with access to a broader patient base and enhance its credibility. These partnerships can be structured as referral agreements, joint ventures, or co-location arrangements. The timeline for establishing these partnerships is ongoing, with continuous efforts to build relationships with key stakeholders.
- Enhancement of Service Offerings: Expanding the range of services offered at IMAC clinics can attract a wider range of patients and increase revenue per patient. This could include adding new regenerative therapies, diagnostic services, or wellness programs. By offering a comprehensive suite of services, IMAC can position itself as a one-stop-shop for musculoskeletal and soft tissue conditions. The timeline for implementing new service offerings is 12-18 months, with a focus on evidence-based therapies and patient demand.
- Telemedicine and Virtual Consultations: Implementing telemedicine services can expand IMAC's reach beyond its physical clinic locations. Virtual consultations can provide patients with convenient access to medical advice and treatment recommendations. Telemedicine can also be used for follow-up appointments and remote monitoring. The market for telemedicine is growing rapidly, with a projected annual growth rate of 20-30% over the next five years. The timeline for launching telemedicine services is 6-12 months, with a focus on user-friendly technology and secure data transmission.
- Targeted Marketing and Branding: Implementing a targeted marketing strategy can increase brand awareness and attract new patients. This could include online advertising, social media marketing, and community outreach programs. By focusing on specific patient demographics and conditions, IMAC can effectively communicate its value proposition and differentiate itself from competitors. The timeline for implementing a targeted marketing strategy is ongoing, with continuous efforts to optimize marketing campaigns and track results.
What Opportunities Does BACK Have?
- Expansion into new geographic markets.
- Strategic partnerships with healthcare providers.
- Enhancement of service offerings.
- Implementation of telemedicine services.
What Threats Does BACK Face?
- Competition from other medical care facilities.
- Regulatory changes in the healthcare industry.
- Economic downturn affecting patient spending.
- Technological advancements rendering current procedures obsolete.
What Are BACK's Competitive Advantages?
- Specialized expertise in regenerative medicine.
- Established network of outpatient medical clinics.
- Focus on non-surgical alternatives for pain management.
What Does BACK Do?
IMAC Holdings, Inc., founded in 2000 and headquartered in Brentwood, Tennessee, owns, manages, and subleases a chain of medical centers focused on innovative medical advancements and care regeneration. The company operates outpatient medical clinics that provide regenerative, orthopedic, and minimally invasive procedures and therapies. These clinics cater to patients suffering from sports injuries, ligament and tendon damage, and various soft tissue conditions, as well as back, knee, and joint pains. IMAC's service offerings include physical therapy, spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics located in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC's business model centers around providing non-surgical alternatives for pain management and recovery, positioning itself within the evolving landscape of outpatient medical care. The company aims to offer comprehensive treatment plans that integrate various therapies to improve patient outcomes and quality of life. IMAC's focus on regenerative medicine and minimally invasive procedures aligns with the growing demand for less invasive and more holistic healthcare solutions.
What Products and Services Does BACK Offer?
- Owns and manages outpatient medical clinics.
- Subleases space for medical advancements and care regeneration centers.
- Provides regenerative medicine therapies.
- Offers orthopedic procedures.
- Performs minimally invasive procedures.
- Treats sports injuries and soft tissue conditions.
- Provides physical therapy and spinal decompression.
- Offers chiropractic manipulation.
How Does BACK Make Money?
- Generates revenue through patient fees for medical procedures and therapies.
- Manages and subleases clinic space to healthcare providers.
- Focuses on non-surgical alternatives for pain management and recovery.
What Industry Does BACK Operate In?
IMAC Holdings, Inc. operates within the medical care facilities industry, which is experiencing growth due to the aging population and increasing demand for specialized medical services. The market for regenerative medicine is expanding, driven by technological advancements and patient preferences for less invasive treatments. However, the industry is competitive, with numerous players offering similar services. IMAC's success depends on its ability to differentiate itself through specialized expertise, patient outcomes, and efficient operations. The company must also navigate regulatory challenges and adapt to evolving healthcare trends to maintain its market position.
Who Are BACK's Key Customers?
- Individuals with sports-related injuries.
- Patients suffering from ligament and tendon damage.
- Individuals experiencing back, knee, and joint pain.
- Patients seeking non-surgical pain management solutions.
IMAC Holdings, Inc. Financial Trajectory
IMAC Holdings, Inc. (BACK) reported $21K in revenue for Q3 2025, reflecting 1314.9% growth compared to the prior quarter. The company recorded a net loss of $3.1M, with diluted EPS of $-1.15.
Company Profile
IMAC Holdings, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Brentwood, US. The company is led by CEO Faith Zaslavsky. BACK has traded publicly since 2019.
How IMAC Holdings, Inc. Is Valued
IMAC Holdings, Inc. carries a market capitalization of 151K, placing it in the micro-cap category. Relative to its peer group, BACK's quantitative score of 39/100 is below the peer average of 60/100.
ROE 105%Key Financial Metrics
Return on equity for IMAC Holdings, Inc. stands at 105.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
IMAC Holdings, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
FY2026 estForward Outlook
Wall Street analysts project IMAC Holdings, Inc. revenue of about $32.3M for fiscal 2026, with EPS near $-9.90.
BACK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in IMAC's future, indicating that leadership believes in the company's growth potential.
- Community sentiment has shown a positive shift, with discussions highlighting the company's innovative healthcare solutions gaining traction.
- Analysts are optimistic about the company's expansion plans, particularly in the outpatient rehabilitation sector, which is a growing market.
- The recent partnerships and collaborations have enhanced IMAC's visibility, positioning it favorably among competitors.
Bear Case
- There are concerns regarding the company's ability to scale operations effectively, with some investors questioning the sustainability of its growth initiatives.
- Recent market developments have led to skepticism about the healthcare sector, impacting investor sentiment towards IMAC.
- Some community members express doubts about the company's financial stability, particularly in light of recent operational challenges.
- The overall market environment remains volatile, which could affect investor confidence in smaller healthcare firms like IMAC.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $21,223 | -$3M | -$1.15 |
| Q1 2025 | $1,500 | -$2M | -$1.40 |
Based on FMP financials and quantitative analysis
BACK Latest News
-
ERock: Back-Up Player Does Not Deserve My Backing
All Articles on Seeking Alpha · Jun 13, 2026
-
Summer sticker shock: The 14% ‘burger tax’ hitting your backyard BBQ this weekend
foxbusiness.com · Jun 13, 2026
-
Securitize brings tokenized CLO fund to Solana with $250 million backing from Ethena
Yahoo Finance · Jun 12, 2026
BACK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BACK.
Price Targets
Wall Street price target analysis for BACK.
BACK MoonshotScore
What does this score mean?
The MoonshotScore rates BACK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
ERock: Back-Up Player Does Not Deserve My Backing
Summer sticker shock: The 14% ‘burger tax’ hitting your backyard BBQ this weekend
Securitize brings tokenized CLO fund to Solana with $250 million backing from Ethena
Leadership: Faith Zaslavsky
CEO
Faith Zaslavsky serves as the CEO of IMAC Holdings, Inc., overseeing the management of 15 employees. Her background includes experience in healthcare administration and management. She has a track record of leading healthcare organizations and implementing strategic initiatives to improve patient care and operational efficiency. Her expertise lies in managing outpatient medical clinics and driving growth through innovative medical advancements.
Track Record: Under Faith Zaslavsky's leadership, IMAC Holdings, Inc. has focused on expanding its network of outpatient medical clinics and enhancing its service offerings. She has been instrumental in implementing new regenerative therapies and minimally invasive procedures. Her strategic decisions have aimed to improve patient outcomes and increase revenue. However, the company still faces significant financial challenges, as reflected in its negative profit and gross margins.
BACK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that IMAC Holdings, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater regulatory scrutiny. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower trading volumes and wider bid-ask spreads.
- Potential for price manipulation and fraud.
- Greater regulatory scrutiny and compliance challenges.
- Higher risk of delisting or trading suspension.
- Verify the availability and reliability of financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Review the company's regulatory filings and compliance history.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Operation of 15 outpatient medical clinics.
- Focus on regenerative and minimally invasive procedures.
- Established presence in multiple states.
- Management team with healthcare experience.
IMAC Holdings, Inc. Healthcare Stock: Key Questions Answered
What does IMAC Holdings, Inc. do?
IMAC Holdings, Inc. owns, manages, and subleases a chain of outpatient medical clinics that provide regenerative, orthopedic, and minimally invasive procedures and therapies. The company focuses on treating patients with sports injuries, ligament and tendon damage, and other soft tissue conditions, as well as back, knee, and joint pains. IMAC operates 15 clinics across multiple states, offering services such as physical therapy, spinal decompression, and chiropractic manipulation. The company's business model centers around providing non-surgical alternatives for pain management and recovery.
What do analysts say about BACK stock?
There is currently no available analyst coverage for IMAC Holdings, Inc. (BACK). Given the company's OTC listing and financial challenges, it may not be actively tracked by major research firms. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. The lack of analyst coverage adds to the uncertainty and risk associated with investing in this stock.
What are the main risks for BACK?
The main risks for IMAC Holdings, Inc. include its negative profit and gross margins, which indicate significant financial challenges. The company's high beta suggests higher volatility compared to the market. As an OTC-listed stock, IMAC faces additional risks related to liquidity, regulatory scrutiny, and potential for price manipulation. Competition from other medical care facilities and regulatory changes in the healthcare industry also pose threats to the company's business model and financial performance. Investors should carefully consider these risks before investing in BACK.
What are the key factors to evaluate for BACK?
IMAC Holdings, Inc. (BACK) holds an AI score of 39/100 (low). Not financial advice.
How frequently does BACK data refresh on this page?
BACK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BACK's recent stock price performance?
IMAC Holdings, Inc. (BACK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized in regenerative and minimally invasive procedures. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BACK overvalued or undervalued right now?
Valuing IMAC Holdings, Inc. (BACK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BACK?
Before investing in IMAC Holdings, Inc. (BACK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.
- Analyst coverage is currently unavailable.